Merck KGaA (OTCMKTS:MKKGY) Sees Large Volume Increase – What’s Next?

Shares of Merck KGaA (OTCMKTS:MKKGY) saw unusually-high trading volume on Monday . Approximately 286,679 shares traded hands during mid-day trading, an increase of 175% from the previous session’s volume of 104,228 shares.The stock last traded at $25.04 and had previously closed at $24.57.

Analyst Upgrades and Downgrades

Separately, Deutsche Bank Aktiengesellschaft lowered Merck KGaA from a “buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. Three analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

Merck KGaA Stock Performance

The firm has a market capitalization of $16.03 billion, a P/E ratio of 11.02, a price-to-earnings-growth ratio of 2.18 and a beta of 0.96. The company’s 50 day moving average is $29.08 and its 200-day moving average is $27.63. The company has a quick ratio of 0.97, a current ratio of 1.49 and a debt-to-equity ratio of 0.36.

Merck KGaA (OTCMKTS:MKKGY) last posted its quarterly earnings results on Thursday, March 5th. The company reported $0.28 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.19). Merck KGaA had a net margin of 12.31% and a return on equity of 9.02%. The company had revenue of $6.11 billion during the quarter, compared to the consensus estimate of $6.20 billion. As a group, equities analysts anticipate that Merck KGaA will post 1.87 EPS for the current year.

About Merck KGaA

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.